Central Pharmaceutical JSC No2

Central Pharmaceutical JSC No2 Current Liabilities

The Current Liabilities of Central Pharmaceutical JSC No2 (DP2.VN) as of Nov 22, 2026 is 246.32 B VND. In the previous year, Current Liabilities was 267.70 B VND — a change of -7.99% (lower).

Current Liabilities

246.32 BVND

YoY

-7.99%

Last updated:

Current Liabilities of Central Pharmaceutical JSC No2 is 2025 246.32 B VND. Current Liabilities of Central Pharmaceutical JSC No2 was 2024 267.70 B VND. It decreases by -7.99% lower compared to the previous year.

The Central Pharmaceutical JSC No2 Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
164.72 B VND
Jan 1, 2019
179.96 B VND
Jan 1, 2020
211.92 B VND
Jan 1, 2021
206.82 B VND
Jan 1, 2022
243.65 B VND
Jan 1, 2023
249.18 B VND
Jan 1, 2024
267.70 B VND
Jan 1, 2025
246.32 B VND
The Central Pharmaceutical JSC No2 Current Liabilities history
YEARCurrent LiabilitiesYoY
246.32 BVND-7.99%
267.70 BVND+7.43%
249.18 BVND+2.27%
243.65 BVND+17.81%
206.82 BVND-2.41%
211.92 BVND+17.76%
179.96 BVND+9.25%
164.72 BVND+5.27%
156.47 BVND+33.47%
117.23 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Central Pharmaceutical JSC No2 Stock analysis

What does Central Pharmaceutical JSC No2 do? Central Pharmaceutical JSC No2 generates revenue through manufacturing and distributing pharmaceutical products such as broad-spectrum antibiotics, tablets, liquid medicines, ointments, capsules, and topical balms. The company also engages in importing and trading medicinal materials and preparations. Its primary customers are healthcare providers and pharmacies across Vietnam, focusing on domestic markets for diversified pharmaceutical solutions. The firm operates within the pharmaceutical sector, leveraging its manufacturing capabilities to supply essential medicines. It targets healthcare institutions and retail pharmacy chains that require consistent access to a wide range of pharmaceutical products. Central Pharmaceutical JSC No2’s business model emphasizes local production and distribution to meet regional demand without relying on international markets or external partnerships. Revenue streams are derived from both product sales and import-trading activities. The company’s product portfolio includes antibiotics, dosage forms like tablets and capsules, and topical treatments such as ointments and balms. These offerings cater to the domestic Vietnamese healthcare sector, where demand for affordable and accessible medicines remains strong. Central Pharmaceutical JSC No2 is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Central Pharmaceutical JSC No2 stock

Current Liabilities of Central Pharmaceutical JSC No2 is 246.32 B VND in 2025.

Current Liabilities of Central Pharmaceutical JSC No2 changed from 267.70 B VND to 246.32 B VND, representing a -7.99% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Central Pharmaceutical JSC No2 since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Central Pharmaceutical JSC No2 historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Central Pharmaceutical JSC No2

All Key Metrics — Central Pharmaceutical JSC No2